1Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA 90033 USA
2The Institute of Cancer Research, London, SW7 3RP UK
3Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, CB1 8RN UK
4Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ UK
5Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH 44106-7219 USA
6Seidman Cancer Center, University Hospitals, Cleveland, OH 44106 USA
7Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892 USA
8Institute of Population Health, University of Manchester, Manchester, M13 9PL UK
9Warwick Medical School, University of Warwick, Coventry, CV4 7AL UK
10Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA 30303 USA
11SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 USA
12Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Brisbane, QLD 4059 Australia
13Translational Research Institute, Brisbane, QLD 4102 Australia
14Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77 Stockholm, Sweden
15Centre for Cancer Genetic Epidemiology, Department of Oncology, Strangeways Laboratory, University of Cambridge, Cambridge, CB1 8RN UK
16Department of Applied Health Research, University College London, London, WC1E 7HB UK
17Department of Medical Biochemistry and Genetics, Institute of Biomedicine, University of Turku, FI-20014 Turku, Finland
18Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, 20521 Turku, Finland
19BioMediTech, University of Tampere, 33520 Tampere, Finland
20Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden
21Division of Cancer Sciences, Manchester Academic Health Science Centre, Radiotherapy Related Research, Manchester NIHR Biomedical Research Centre, The Christie Hospital NHS Foundation Trust, University of Manchester, Manchester, M13 9PL UK
22Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115 USA
23Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.HChan School of Public Health, Boston, MA 02115 USA
24GRC N°5 ONCOTYPE-URO, UPMC Univ Paris 06, Tenon Hospital, F-75020 Paris, France
25CeRePP, Tenon Hospital, F-75020 Paris, France
26Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
27Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark
28Department of Medical Genetics, Oslo University Hospital, 0424 Oslo, Norway
29Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA
30Department of Oncology, Addenbrooke’s Hospital, University of Cambridge, Cambridge, CB2 0QQ UK
31Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, CB2 0RE UK
32Nuffield Department of Surgical Sciences, University of Oxford, Oxford, OX1 2JD UK
33School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS UK
34Cancer Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF UK
35Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9 Canada
36Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA
37Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029-5674 USA
38Centre for Molecular Oncology, Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, EC1M 6BQ UK
39Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC 3004 Australia
40Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010 Australia
41Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA 02115 USA
42Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, 15706 Santiago de Compostela, Spain
43Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Columbia, SC 29208 USA
44Centre for Research in Environmental Epidemiology (CREAL), Barcelona Institute for Global Health (ISGlobal), 08003 Barcelona, Spain
45CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain
46IMIM (Hospital del Mar Research Institute), 08003 Barcelona, Spain
47Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain
48Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA 02184 USA
49Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL 33612 USA
50Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024 USA
51Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA 98195 USA
52International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 70-115 Szczecin, Poland
53Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
54Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200 Copenhagen, Denmark
55Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany
56German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany
57Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany
58Institute for Human Genetics, University Hospital Ulm, 89075 Ulm, Germany
59Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA
60Department of Genetics, Portuguese Oncology Institute of Porto, 4200-072 Porto, Portugal
61Biomedical Sciences Institute (ICBAS), University of Porto, 4050-313 Porto, Portugal
62Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA 91010 USA
63Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, B-9000 Gent, Belgium
64Faculty of Medicine, Department of Surgery, University of Malaya, 50603 Kuala Lumpur, Malaysia
65Department of Urology, University of Washington, Seattle, WA 98195 USA
66Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, D-20246 Hamburg, Germany
67Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, 1431 Sofia, Bulgaria
68Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2 Canada
69Division of Radiation Oncology, Cross Cancer Institute, Edmonton, AB T6G 1Z2 Canada
70Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, BE-3000 Leuven, Belgium
71Manchester Cancer Research Centre, Faculty of Biology Medicine and Health, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, M13 9WL UK
72Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, 15706 Santiago de Compostela, Spain
73Moores Cancer Center, University of California San Diego, La Jolla, CA 92037 USA
74Department of Urology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
75Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, 94807 Villejuif Cédex, France
76Clinical Gerontology Unit, University of Cambridge, Cambridge, CB2 2QQ UK
77Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112 USA
78George EWahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148 USA
79The University of Surrey, Guildford, Surrey, GU2 7XH UK
80Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905 USA
81Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905 USA
82Royal Marsden NHS Foundation Trust, London, SW3 6JJ UK
83Molecular Cancer Epidemiology Laboratory, QIMR Berghofer Institute of Medical Research, Herston, QLD 4006 Australia
84School of Medicine, University of Queensland, Herston, QLD 4006 Australia
85Royal Brisbane and Women’s Hospital, Herston, QLD 4029 Australia
86The Kinghorn Cancer Centre (TKCC), Victoria, NSW 2010 Australia
87Prostate Cancer Research Group, South Australian Health and Medical Research Institute, Adelaide, SA 5000 Australia
88Department of Physiology, Biomedicine Discovery Institute, Cancer Program, Monash University, Melbourne, VIC 3800 Australia
89University of Adelaide, North Terrace, Adelaide, SA 5005 Australia
90Fimlab Laboratories, Tampere University Hospital, FI-33520 Tampere, Finland
91Finnish Cancer Registry, FI-00130 Helsinki, Finland
92Department of Urology, Helsinki University Central Hospital and University of Helsinki, FI-00014 Helsinki, Finland
93Division of Biostatistics and Bioinformatics, University of Maryland Greenebaum Cancer Center, and Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD 21201 USA
94Cancer Genomics Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, FNLCR Leidos Biomedical Research, National Cancer Institute, Frederick, MD 21701 USA
95Division of Cancer Epidemiology and Genetics, DNA Extraction and Staging Laboratory (DESL), Cancer Genomics Research Laboratory (CGR), FNLCR Leidos Biomedical Research, National Cancer Institute, Frederick, MD 21701 USA
96Sheffield Institute for Nucleic Acids, University of Sheffield, Sheffield, S10 2TN UK
97Cambridge Cancer Trials Centre, Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ UK
98Department of Medical Imaging, University Health Network, Toronto, ON M5G 2C4 Canada
99Department of Pathology, University Health Network, Toronto, ON M5G 2C4 Canada
100Advanced Radiation Biology Research Program, Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, 263-8555 Japan
101Department of Urology, National Hospital Organization Tokyo Medical Center, Tokyo, 152-8902 Japan
102Department of Urology, Nanfang Hospital, Southern Medical University, 510515 Guangzhou, China
103Department of Pathology, The First Affiliated Hospital, Zhejiang University Medical College, 310009 Hangzhou, China
104Department of Pathology, Changhai Hospital, The Second Military Medical University, 200433 Shanghai, China
105Department of Urology, First Affiliated Hospital, Medical College, Zhengzhou University, 450003 Zhengzhou, China
106Department of Urology, North Sichuan Medical College, 637000 Nanchong, China
107Department of Nutrition Science, Shenyang Medical College, 110034 Shenyang, China
108Tissupath Pty Ltd., Melbourne, VIC 3122 Australia
109Department of Medical Physics, Complexo Hospitalario Universitario de Santiago, SERGAS, 15706 Santiago de Compostela, Spain
110Urology Department, Hospital Germans Trias I Pujol, 08916 Barcelona, Spain
111Laboratory and Department of Urology, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, 08036 Barcelona, Spain
112Centre de Recerca Biomèdica CELLEX, 08036 Barcelona, Spain
113Department and Laboratory of Urology, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, 08036 Barcelona, Spain
114Genitourinary Program, Moffitt Cancer Center, Tampa, FL 33612 USA
115Department of Urology, Klinikum rechts der Isar der Technischen Universitaet Muenchen, 81675 Munich, Germany
116Department of General and Clinical Pathology, Alexandrovska University Hospital, Medical University, 1431 Sofia, Bulgaria
117Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, 2252 3270 Saudi Arabia
118Grupo de Medicina Xenómica, CIBERER, CIMUS, Universidad de Santiago de Compostela, Avenida de Barcelona, 15782 Santiago de Compostela, Spain
119Hérault Cancer Registry, Montpellier cedex 5, Montpellier, 34298 France
120Urology Department, Clinique Beau Soleil, 34070 Montpellier, France
121INSERM U1147, 75013 Paris, France
122Department of Clinical Science, Intervention and Technology, Karolinska Institutet, SE-171 77 Stockholm, Sweden
123Swedish Agency for Health Technology Assessment and Assessment of Social Services, SE-102 33 Stockholm, Sweden
124Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, SE-901 85 Umeå, Sweden
125Department of Surgical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden
126Faculty of Medicine and Health, Department of Urology, Örebro University, SE-701 82 Örebro, Sweden
127Medical Research Council (MRC) Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN UK
128National Institute for Health Research (NIHR) Biomedical Research Centre, University of Bristol, Bristol, BS8 1TH UK
129Department of Urology, Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 USA
130Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD 4222 Australia
131Cancer Council Queensland, Fortitude Valley, QLD 4006 Australia
132Chris O’Brien Lifehouse (COBLH), Camperdown, Sydney, NSW 2010 Australia
133Garvan Institute of Medical Research, Sydney, NSW 2010 Australia
134Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, SA 5005 Australia
135Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800 Australia
136Prostate Cancer Translational Research Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000 Australia
137Department of Molecular Medicine and Surgery, Karolinska Institutet, and Department of Urology, Karolinska University Hospital, 171 76 Stockholm, Sweden
138Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, 182 88 Stockholm, Sweden
139Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA UK
140Department of Urology, Tampere University Hospital, University of Tampere, Kalevantie 4, FI-33014 Tampere, Finland
141Faculty of Medicine and Life Sciences, University of Tampere, FI-33014 Tampere, Finland
142Department of Epidemiology, School of Health Sciences, University of Tampere, FI-33014 Tampere, Finland
143University of Cambridge Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB1 8RN UK
144Washington University School of Medicine, StLouis, MO 63110 USA
145Department of Urology, Aarhus University Hospital, 8200 Aarhus N, Denmark
146Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY 14620 USA
147Professor of Pathology and Pediatrics, Albert Einstein College of Medicine, Bronx, NY 10461 USA
148Second Military Medical University, 200433 Shanghai, China
149Wuxi Second Hospital, Nanjing Medical University, 214003 Wuxi, Jiangzhu China
150Department of Urology, The First Affiliated Hospital, Chongqing Medical University, 200032 Chongqing, China
151The People’s Hospital of Liaoning Province and The People’s Hospital of China Medical University, 110001 Shenyang, China
152Department of Urology, Zhongshan Hospital, Fudan University Medical College, 200032 Shanghai, China
153Precision Medicine, School and Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168 Australia
154Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS 7000 Australia
155Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, OX1 2JD UK
156Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, 15706 Santiago de Compostela, Spain
157Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska Institutet, Huddinge, SE-171 77 Stockholm, Sweden
158Scandinavian Development Services, 182 33 Danderyd, Sweden
159University of Cantabria-IDIVAL, 39005 Santander, Spain
160School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112 USA
161National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892 USA
162Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200 Copenhagen, Denmark
163Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, DK-2730 Herlev, Denmark
164Saarland Cancer Registry, 66119 Saarbrücken, Germany
165Department of Urology, University Hospital Ulm, 89075 Ulm, Germany
166Cancer Prevention Institute of California, Fremont, CA 94538 USA
167Department of Health Research and Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305-5101 USA
168Department of Radiotherapy, Ghent University Hospital, B-9000 Gent, Belgium
169Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, 47500 Subang Jaya, Selangor Malaysia
170Division of Medical Oncology, Urogenital Unit, Department of Oncology at the University Hospital Centre Zagreb, Šalata 2, 10000 Zagreb, Croatia
171Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Šalata 2, 10000 Zagreb, Croatia
172Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, 1431 Sofia, Bulgaria
173Department of Urology, University Hospitals Leuven, BE-, 3000 Leuven, Belgium
174Southampton General Hospital, The University of Southampton, Southampton, SO16 6YD UK
175Genetic Oncology Unit, CHUVI Hospital, Complexo Hospitalario Universitario de Vigo, Instituto de Investigación Biomédica Galicia Sur (IISGS), 36204 Vigo (Pontevedra), Spain
176Moores Cancer Center, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA 92093-0012 USA
177Department of Clinical Chemistry, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
178Program for Personalized Cancer Care, NorthShore University Health System, Evanston, IL 60201 USA
179Department of Epidemiology, University of Washington, Seattle, WA 98195 USA
180Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, SW7 2AZ UK
181Genomics England, Queen Mary University of London, Dawson Hall, Charterhouse Square, London, EC1M 6BQ UK
182Genomic Epidemiology Group, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany
183Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI 96813 USA
184Dana-Farber Cancer Institute, Boston, MA 02215 USA
185Paris-Sud University, UMRS 1018, Cedex 94807 Villejuif, France